Company Search:
Advanced Search
Sponsored Links
Ablynx N.V. Company Snapshot
Ablynx N.V. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ablynx N.V. with three other miscellaneous service companies in Europe: Galapagos NV (2015 sales of 60.58 million Euro [US$66.50 million] of which 91% was R&D), Cellectis SA of France (56.39 million Euro [US$61.89 million] of which 101% was Therapeutics), and Medivir AB which is based in Sweden (657.89 million Swedish Kronor [US$74.53 million] of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2015, sales at Ablynx N.V. were 77.54 million Euro (US$85.11 million). This is an increase of 57.3% versus 2014, when the company's sales were 49.30 million Euro. This was the fourth straight year of sales growth at Ablynx N.V..
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ablynx N.V.
  Stock Performance Chart for Ablynx N.V.
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 10.99
(Figures in Euro)
1 Week 0.6%   13 Weeks -2.8%  
4 Weeks -9.9%   52 Weeks -7.2%  
Ablynx N.V. Key Data:
  Ticker: ABLX Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 77,540,000
(Year Ending Jan 2016).
Employees: 344
  Currency: Euro Market Cap: 668,667,122
  Fiscal Yr Ends: December Shares Outstanding: 60,870,926
  Share Type: ACTIONS ORDINAIRES Closely Held Shares: 5,433,214
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.